Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

QNCX Quince Therapeutics Inc

0,7801

-0,0602 (-7,16%)

Zuletzt aktualisiert: 20:20:58

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Quince Therapeutics Charts.

Quince Therapeutics (NASDAQ:QNCX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Quince Therapeutics Charts.

News Quince Therapeutics Inc

Form 8-K - Current report
Donnerstag 6 Juni 2024 (21 Stunden vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 Juni 2024 (2 Tage vor) • Edgar (US Regulatory)

Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
Montag 3 Juni 2024 (4 Tage vor) • Business Wire

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Montag 13 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
Montag 13 Mai 2024 (4 Wochen vor) • Business Wire

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference
Montag 6 Mai 2024 (1 Monat vor) • Business Wire

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results
Montag 1 April 2024 (2 Monate vor) • Business Wire

Quince Therapeutics Launches Scientific Advisory Board
Donnerstag 22 Februar 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Donnerstag 15 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors
Donnerstag 15 Februar 2024 (4 Monate vor) • Business Wire

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
Mittwoch 7 Februar 2024 (4 Monate vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 2 Februar 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Quince Therapeutics Inc News-Artikel

Financial Select Sector

Euro vs US Dollar

Deutsche Lufthansa

BNP Paribas (QX)

Energy Select Sector SPDR

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen